TERRY LAIN: Open Payments
NPI 1295751006 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 18 payments from 7 companies in 2025. Trend: 2023 $320 · 2024 $435 · 2025 $409
Food & beverage: $409
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $121 |
| Vanda Pharmaceuticals Inc. | 4 | $96 |
| Janssen Pharmaceuticals, Inc | 3 | $73 |
| Indivior Inc. | 1 | $40 |
| Alkermes, Inc. | 2 | $34 |
| ABBVIE INC. | 2 | $31 |
| Lundbeck LLC | 1 | $15 |
Products named: REXULTI, FANAPT, INVEGA, SUBLOCADE, VRAYLAR, ARISTADA, VIVITROL, ABILIFY ASIMTUFII.
Industry payments across LA — which companies pay providers there.
